Page results
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
Patient Advice and Liaison Service (PALS)
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
We are very excited that the Omnipod 5 has now been launched. The team have been busy over the last few months getting training and ensuring that the pump is on our procurement system.
-
UCLH Find & Treat team explain why screening is vital on World Hepatitis Day
-
A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.
-
The Macmillan Support and Information Service celebrates its developments and achievements since opening ten years ago.
-
Using MRI alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to research from UCLH, UCL and King’s College London.
File results
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI201730 Cancelled cancer operations
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology